JP2020515557A5 - - Google Patents

Download PDF

Info

Publication number
JP2020515557A5
JP2020515557A5 JP2019552891A JP2019552891A JP2020515557A5 JP 2020515557 A5 JP2020515557 A5 JP 2020515557A5 JP 2019552891 A JP2019552891 A JP 2019552891A JP 2019552891 A JP2019552891 A JP 2019552891A JP 2020515557 A5 JP2020515557 A5 JP 2020515557A5
Authority
JP
Japan
Prior art keywords
salt
compound selected
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019552891A
Other languages
English (en)
Japanese (ja)
Other versions
JP7032428B2 (ja
JP2020515557A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2018/058056 external-priority patent/WO2018178227A1/en
Publication of JP2020515557A publication Critical patent/JP2020515557A/ja
Publication of JP2020515557A5 publication Critical patent/JP2020515557A5/ja
Application granted granted Critical
Publication of JP7032428B2 publication Critical patent/JP7032428B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019552891A 2017-03-31 2018-03-29 Mcl-1阻害剤の合成 Active JP7032428B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762479493P 2017-03-31 2017-03-31
US62/479,493 2017-03-31
PCT/EP2018/058056 WO2018178227A1 (en) 2017-03-31 2018-03-29 Synthesis of mcl-1 inhibitor

Publications (3)

Publication Number Publication Date
JP2020515557A JP2020515557A (ja) 2020-05-28
JP2020515557A5 true JP2020515557A5 (enExample) 2021-03-11
JP7032428B2 JP7032428B2 (ja) 2022-03-08

Family

ID=61827753

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019552891A Active JP7032428B2 (ja) 2017-03-31 2018-03-29 Mcl-1阻害剤の合成

Country Status (16)

Country Link
US (1) US11149024B2 (enExample)
EP (1) EP3601230B1 (enExample)
JP (1) JP7032428B2 (enExample)
KR (1) KR102604876B1 (enExample)
CN (1) CN110536884B (enExample)
AR (1) AR111304A1 (enExample)
AU (1) AU2018244180B2 (enExample)
CA (1) CA3056712A1 (enExample)
CO (1) CO2019010035A2 (enExample)
EA (1) EA038226B1 (enExample)
ES (1) ES2909751T3 (enExample)
IL (1) IL269410B2 (enExample)
MX (1) MX387814B (enExample)
TW (1) TWI781996B (enExample)
WO (1) WO2018178227A1 (enExample)
ZA (1) ZA201905645B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11691989B2 (en) 2018-11-22 2023-07-04 Ascentage Pharma (Suzhou) Co., Ltd. Macrocyclic indoles as Mcl-1 inhibitors
US12319703B2 (en) 2019-01-23 2025-06-03 Ascentage Pharma (Suzhou) Co., Ltd. Macrocyclic fused pyrazoles as Mcl-1 inhibitors
KR20220024694A (ko) 2019-06-21 2022-03-03 얀센 파마슈티카 엔.브이. Mcl-1의 거대환식 억제제
WO2021005043A1 (en) 2019-07-09 2021-01-14 Janssen Pharmaceutica Nv Macrocyclic spirocycle derivatives as mcl-1 inhibitors
WO2021092053A1 (en) * 2019-11-08 2021-05-14 Unity Biotechnology, Inc. Mcl-1 inhibitor macrocycle compounds for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer
WO2021099579A1 (en) 2019-11-21 2021-05-27 Janssen Pharmaceutica Nv Macrocyclic indole derivatives as mcl-1 inhibitors
MX2022006180A (es) 2019-11-21 2022-06-14 Janssen Pharmaceutica Nv Derivados macrociclicos de sulfonilo como inhibidores de mcl-1.
JP2023514364A (ja) 2020-02-21 2023-04-05 ヤンセン ファーマシューティカ エヌ.ベー. Mcl-1の阻害剤としての大環状インドール誘導体
EP4157852A1 (en) 2020-05-29 2023-04-05 JANSSEN Pharmaceutica NV Macrocyclic 7-pyrazol-5-yl-indole derivatives as inhibitors of mcl-1
MX2022015998A (es) * 2020-06-19 2023-04-12 Janssen Pharmaceutica Nv Derivados de 4-(pirazol-5-il)-indol macrocíclico unidos a n como inhibidores de mcl-1.
WO2021255257A1 (en) 2020-06-19 2021-12-23 Janssen Pharmaceutica Nv N-linked macrocyclic 7-(pyrazol-5-yl)-indole derivatives as inhibitors of mcl-1
CA3184877A1 (en) 2020-07-08 2022-01-13 Benoit Christian Albert Ghislain De Boeck Macrocyclic ether containing indole derivatives as inhibitors of mcl-1
WO2022032284A1 (en) * 2020-08-07 2022-02-10 Zeno Management, Inc. Macrocyclic compounds
JP2023553719A (ja) 2020-12-17 2023-12-25 ヤンセン ファーマシューティカ エヌ.ベー. Mcl-1阻害剤としての分岐大環状4-(ピラゾール-5-イル)-インドール誘導体
JP2024506648A (ja) 2021-02-12 2024-02-14 ヤンセン ファーマシューティカ エヌ.ベー. がんの治療のためのmcl-1阻害剤としての大環状1,3-架橋6-クロロ-7-ピラゾール-4-イル-1h-インドール-2-カルボキシレート及び6-クロロ-7-ピリミジン-5-イル-1h-インドール-2-カルボキシレート誘導体
US11931424B2 (en) 2021-06-11 2024-03-19 Gilead Sciences, Inc. Combination MCL-1 inhibitors with anti-body drug conjugates
WO2022261301A1 (en) 2021-06-11 2022-12-15 Gilead Sciences, Inc. Combination mcl-1 inhibitors with anti-cancer agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2915811A1 (en) * 2014-03-04 2015-09-09 Centre Régional de Lutte contre le Cancer - Centre François Baclesse MCL-1 modulating compounds for cancer treatment
US9949965B2 (en) * 2014-10-17 2018-04-24 Vanderbilt University Tricyclic indole Mcl-1 inhibitors and uses thereof
CN105061315B (zh) * 2015-08-06 2017-10-24 大连理工大学 一类1,5‑二苯基吡唑‑3‑羧酸类化合物及其应用
MX386103B (es) * 2016-04-22 2025-03-18 Astrazeneca Ab Inhibidores de mcl-1 y metodos de uso de los mismos.
CN106478606B (zh) * 2016-09-21 2019-05-10 沈阳药科大学 N-取代吲哚类衍生物及其应用

Similar Documents

Publication Publication Date Title
JP2020515557A5 (enExample)
JP2019194236A5 (enExample)
JP2017008120A5 (enExample)
JP2018024670A5 (enExample)
JP2019089762A5 (enExample)
JP2021020948A5 (enExample)
JP2018150298A5 (enExample)
JP2020007340A5 (enExample)
JP2020534795A5 (enExample)
JP2019068846A5 (enExample)
JP2019124943A5 (enExample)
JP2017214405A5 (enExample)
JP2019099571A5 (enExample)
JP2020530297A5 (enExample)
JP2021502066A5 (enExample)
JP2017514877A5 (enExample)
JP2017137500A5 (enExample)
JP2018030858A5 (enExample)
JP2018135352A5 (enExample)
JP2018154848A5 (enExample)
JP2019031552A5 (enExample)
JP2021503553A5 (enExample)
JP2019164961A5 (enExample)
JP2018116258A5 (enExample)
JP2018111825A5 (enExample)